Beihai Gofar Chuanshan Biological Balance Sheet Health
Financial Health criteria checks 3/6
Beihai Gofar Chuanshan Biological has a total shareholder equity of CN¥867.6M and total debt of CN¥10.5M, which brings its debt-to-equity ratio to 1.2%. Its total assets and total liabilities are CN¥1.0B and CN¥174.4M respectively.
Key information
1.2%
Debt to equity ratio
CN¥10.53m
Debt
Interest coverage ratio | n/a |
Cash | CN¥133.76m |
Equity | CN¥867.63m |
Total liabilities | CN¥174.38m |
Total assets | CN¥1.04b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 600538's short term assets (CN¥515.2M) exceed its short term liabilities (CN¥166.9M).
Long Term Liabilities: 600538's short term assets (CN¥515.2M) exceed its long term liabilities (CN¥7.4M).
Debt to Equity History and Analysis
Debt Level: 600538 has more cash than its total debt.
Reducing Debt: 600538's debt to equity ratio has increased from 0% to 1.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if 600538 has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 600538 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.